調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Clinical Risk Grouping Solutions Market by Product (Scorecard & Visualization Tools, Dashboard Analytics, Risk Reporting), Deployment (Private Cloud, Public Cloud, Hybrid Cloud), End-User and Region - Global Forecast to 2024

臨床的リスク分類ソリューションの世界市場予測（～2024年）

◆タイトル：Clinical Risk Grouping Solutions Market by Product (Scorecard & Visualization Tools, Dashboard Analytics, Risk Reporting), Deployment (Private Cloud, Public Cloud, Hybrid Cloud), End-User and Region - Global Forecast to 2024
◆商品コード：HIT 7312
◆調査・発行会社：MarketsandMarkets
◆発行日：2019年8月30日
◆ページ数：130
◆レポート形式：PDF / 英語
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥544,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥896,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

当調査レポートでは、臨床的リスク分類ソリューションの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別（スコアカード及び視覚化ツール、ダッシュボード分析、リスク報告）分析、展開別（プライベートクラウド、パブリッククラウド、ハイブリッドクラウド）分析、エンドユーザー別分析、臨床的リスク分類ソリューションの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。MarketsandMarkets社は、臨床的リスク分類ソリューションの世界市場規模が2019年427百万ドルから2024年829百万ドルまで年平均14.2%成長すると予測しています。

Increasing focus on risk management solutions is expected to drive the growth of the clinical risk grouping solutions marketThe clinical risk grouping solutions market is projected to reach USD 829 million by 2024 from USD 427 million in 2019, at a CAGR of 14.2%. Focus on risk management and big data solutions are driving the market for clinical risk grouping solutions. However, a lack of infrastructure for supporting this technology is expected to restrain the growth of the market to a certain extent during the forecast period.

Dashboard analytics segment to show the fastest growth during the forecast period
Based on product, the clinical risk grouping solutions market is segmented into three major categories, viz., scorecard & visualization tools, dashboard analytics, and risk reporting. The dashboard analytics segment is expected to witness one of the highest CAGR within the clinical risk grouping solutions market. High adoption of dashboard analytics by healthcare providers, the increasing adoption of risk management solutions in the healthcare industry, growing requirements for accuracy & quality of patient care, and the rising use of big data solutions in healthcare are driving the growth of the segment.

Private cloud to hold the largest share of the clinical risk grouping solutions market during the forecast period
Based on the deployment model, the clinical risk grouping solutions market is segmented into private cloud, public cloud, and hybrid cloud. In 2018, the private cloud segment accounted for the dominant share of the clinical risk grouping solutions market. The large share of this segment is attributed to the fact that private cloud deployment offers the best security for sensitive data. Additionally, a private cloud offers on-demand infrastructure with dedicated resources that can be shared across domains, applications, and units within the same organization.

North America accounted for the largest share of the market in 2018, whereas the Asia Pacific is expected to be the fastest-growing market
The study discusses the clinical risk grouping solutions market trends for North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the global clinical risk grouping solutions market. The large share of North America can be attributed to the support for adopting HCIT by providers and payers, increasing focus on population health services, and greater availability of clinical risk grouping solutions

However, Asia Pacific is expected to be the fastest-growing market with the highest CAGR during the forecast period. Factors such as the presence of a larger patient population demanding better healthcare at lower costs, economic growth, rising geriatric population, emergence of big data in healthcare, and the growing focus of various market players on emerging Asian countries are expected to drive the growth of the clinical risk grouping solutions market in the Asia Pacific.

The breakup of primary participants is as mentioned below:
• By Company Type: Tier 1 (50%), Tier 2 (10%), and Tier 3 (40%)
• By Designation: C-level (10%), Director-level (30%), and Others (60%)
• By Region: North America (40%), Europe (30%), Asia Pacific (10%), Latin America (10%), and the Middle East and Africa (10%)

The prominent players in the global clinical risk grouping solutions market are 3M Corporation (US), Optum Inc. (US), Cerner Corporation (US), Conduent Inc. (US), Nuance Communications (US), Health Catalyst (US), HBI Solutions (US), Johns Hopkins University (US), Lightbeam Health Solutions (US), Dynamic Healthcare Systems (US), 4S Information Systems (US), Evolent Health (US), and PeraHealth (US).

Research Coverage:
The report analyzes the clinical risk grouping solutions market and aims at estimating the market size and future growth potential of this market based on various segments such as product, deployment model, end user, and region. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:
• Market Penetration: Comprehensive information on the product portfolios of the top players in the global clinical risk grouping solutions market. The report analyzes this market by product, deployment model, end-user, and region
• Product Enhancement/Innovation: Detailed insights on the upcoming trends and product launches in the global clinical risk grouping solutions market
• Market Development: Comprehensive information on the lucrative emerging markets by product, deployment model, end-user, and region
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global clinical risk grouping solutions market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of leading players in the global clinical risk grouping solutions market

【レポートの目次】

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered For the Study
1.4 Currency
1.5 Stakeholders
1.6 Limitations
2 Research Methodology (Page No. – 19)
2.1 Research Approach
2.1.1 Secondary Research
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Research
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Breakdown of Primaries
2.1.2.3 Key Industry Insights
2.2 Market Size Estimation
2.3 Data Triangulation Approach
2.4 Market Share Estimation
2.5 Assumptions For the Study
3 Executive Summary (Page No. – 26)
4 Premium Insights (Page No. – 29)
4.1 Clinical Risk Grouping Solutions: Market Overview
4.2 Clinical Risk Grouping Solutions Market: Geographic Growth Opportunities
4.3 Regional Mix: Clinical Risk Grouping Solutions Market (2019–2024)
4.4 Clinical Risk Grouping Solutions Market: Developed vs. Developing Markets
5 Market Overview (Page No. – 32)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Focus on Risk Management
5.2.1.2 Rising Usage of Big Data Solutions
5.2.2 Restraints
5.2.2.1 Lack of Infrastructure
5.2.3 Opportunities
5.2.3.1 Increasing Physician Burnout Due to Documentation Needs
5.2.3.2 Increasing Focus on Ai and Machine Learning
5.2.4 Challenges
5.2.4.1 Scarcity of Skilled Healthcare It Professionals
5.2.4.2 Patient Data Privacy Concerns
5.2.5 Burning Issue
5.2.5.1 Implementation of Solutions Reduces Administrative Expenses But Increases the Burden on Patients
6 Clinical Risk Grouping Solutions Market, By Product (Page No. – 37)
6.1 Introduction
6.2 Scorecards & Visualization Tools
6.2.1 Need to Increase Patient Accuracy and Forecast Risks are Driving Demand For Scorecards & Visualization Tools
6.3 Dashboard Analytics Solutions
6.3.1 Dashboard Analytics Segment to Register the Highest Growth During the Forecast Period
6.4 Risk Reporting Solutions
6.4.1 Increasing Adoption of Risk Management Solutions By Healthcare Providers to Fuel Market Growth
7 Clinical Risk Grouping Solutions Market, By Deployment Model (Page No. – 44)
7.1 Introduction
7.2 Private Cloud
7.2.1 High Data Security of Private Cloud Models is Driving Market Growth
7.3 Public Cloud
7.3.1 Price-Effectiveness of Public Over Private Clouds has Driven End-User Preference
7.4 Hybrid Cloud
7.4.1 Hybrid Cloud Architecture Provide Flexibility and the Ability to Avoid Vendor Lock-In
8 Clinical Risk Grouping Solutions Market, By End User (Page No. – 49)
8.1 Introduction
8.2 Hospitals
8.2.1 Hospitals are the Largest End Users of the Clinical Risk Grouping Solutions Market
8.3 Payers
8.3.1 Payers Use Clinical Risk Grouping Solutions For Risk Management, Identifying Claims Trends, and Maximizing Payment Accuracy
8.4 Ambulatory Care Centers
8.4.1 Implementation of Mandates to Comply With Quality Measures to Support the Adoption of Clinical Risk Grouping Solutions in Ambulatory Care Centers
8.5 Long-Term Care Centers
8.5.1 Growing Number of Long-Term Care Centers to Drive Market Growth
8.6 Other End Users
9 Clinical Risk Grouping Solutions Market, By Region (Page No. – 59)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 US Dominates the North American Clinical Risk Grouping Solutions Market
9.2.2 Canada
9.2.2.1 Growing Need For Cost Containment in Healthcare Will Propel Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Infrastructural Development and Focus on Risk Management Have Driven Market Growth in Germany
9.3.2 UK
9.3.2.1 Favorable Regulatory Outlook has Pushed the Adoption of Hcit Solutions in the UK
9.3.3 France
9.3.3.1 Initiatives Taken By the French Government to Promote the Use of Healthcare It Solutions Will Drive Market Growth
9.3.4 Rest of Europe (RoE)
9.4 Asia Pacific
9.4.1 Asia is Expected to Witness High Growth in Population and Demand For Healthcare Services
9.5 Latin America
9.5.1 Countries Such as Brazil and Mexico are Exploring New Methods to Manage Clinical Information
9.6 Middle East and Africa
9.6.1 Middle Eastern Countries are Investing Significantly in Hcit Infrastructural Development
10 Competitive Landscape (Page No. – 84)
10.1 Introduction
10.2 Competitive Leadership Mapping
10.2.1 Visionary Leaders
10.2.2 Innovators
10.2.3 Dynamic Differentiators
10.2.4 Emerging Companies
10.3 Company Analysis, By Product and End User
10.4 Competitive Situations and Trends
11 Company Profile (Page No. – 90)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
11.1 3M Company
11.2 Optum Inc. (Subsidiary of Unitedhealth Group Inc.)
11.3 Nuance Communications
11.4 Conduent Incorporated
11.5 Cerner Corporation
11.6 HBI Solutions, Inc.
11.7 4S Information Systems Ltd.
11.8 Johns Hopkins University
11.9 Lightbeam Health Solutions, Llc
11.10 Dynamic Healthcare Systems, Inc.
11.11 Perahealth, Inc.
11.12 Health Catalyst Inc.
11.13 Evolent Health
*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 121)
12.1 Market Sizing & Validation Approach
12.2 Discussion Guide
12.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.4 Available Customizations
12.5 Related Reports
12.6 Author Details

List of Tables (66 Tables)
Table 1 Exchange Rates Utilized For Conversion to USD
Table 2 Clinical Risk Grouping Solutions Market, By Product, 2017–2024 (USD Million)
Table 3 Scorecards and Visualization Tools: Key Brands
Table 4 Scorecards & Visualization Tools Market, By Region, 2017–2024 (USD Million)
Table 5 Dashboard Analytics: Key Brands
Table 6 Dashboard Analytics Solutions Market, By Region, 2017–2024 (USD Million)
Table 7 Risk Reporting: Key Brands
Table 8 Risk Reporting Solutions Market, By Region, 2017–2024 (USD Million)
Table 9 Clinical Risk Grouping Solutions Market, By Deployment Model, 2017–2024 (USD Million)
Table 10 Private Cloud-Deployed Clinical Risk Grouping Solutions Market, By Country/Region, 2017–2024 (USD Million)
Table 11 Public Cloud-Deployed Clinical Risk Grouping Solutions Market, By Country/Region, 2017–2024 (USD Million)
Table 12 Hybrid Cloud-Deployed Clinical Risk Grouping Solutions Market, By Country/Region, 2017–2024 (USD Million)
Table 13 Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 14 Clinical Risk Grouping Solutions For Hospitals
Table 15 Clinical Risk Grouping Solutions Market For Hospitals, By Country/Region, 2017–2024 (USD Million)
Table 16 Clinical Risk Grouping Solutions For Payers
Table 17 Clinical Risk Grouping Solutions Market For Payers, By Country/Region, 2017–2024 (USD Million)
Table 18 Clinical Risk Grouping Solutions For Ambulatory Care Centers
Table 19 Clinical Risk Grouping Solutions Market For Ambulatory Care Centers, By Country/Region, 2017–2024 (USD Million)
Table 20 Clinical Risk Grouping Solutions For Long-Term Care Centers
Table 21 Clinical Risk Grouping Solutions Market For Long-Term Care Centers, By Country/Region, 2017–2024 (USD Million)
Table 22 Clinical Risk Grouping Solutions Market For Other End Users, By Country/Region, 2017–2024 (USD Million)
Table 23 Clinical Risk Grouping Solutions Market, By Region, 2017–2024 (USD Million)
Table 24 North America: Clinical Risk Grouping Solutions Market, By Country, 2017–2024 (USD Million)
Table 25 North America: Clinical Risk Grouping Solutions Market, By Product, 2017–2024 (USD Million)
Table 26 North America: Clinical Risk Grouping Solutions Market, By Deployment Model, 2017–2024 (USD Million)
Table 27 North America: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 28 US: Key Macroindicators
Table 29 US: Clinical Risk Grouping Solutions Market, By Product, 2017–2024 (USD Million)
Table 30 US: Clinical Risk Grouping Solutions Market, By Deployment Model, 2017–2024 (USD Million)
Table 31 US: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 32 Canada: Key Macroindicators
Table 33 Canada: Clinical Risk Grouping Solutions Market, By Product, 2017–2024 (USD Million)
Table 34 Canada: Clinical Risk Grouping Solutions Market, By Deployment Model, 2017–2024 (USD Million)
Table 35 Canada: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 36 Europe: Clinical Risk Grouping Solutions Market, By Country, 2017–2024 (USD Million)
Table 37 Europe: Clinical Risk Grouping Solutions Market, By Product, 2017–2024 (USD Million)
Table 38 Europe: Clinical Risk Grouping Solutions Market, By Deployment Model, 2017–2024 (USD Million)
Table 39 Europe: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 40 Germany: Key Macroindicators
Table 41 Germany: Clinical Risk Grouping Solutions Market, By Product, 2017–2024 (USD Million)
Table 42 Germany: Clinical Risk Grouping Solutions Market, By Deployment Model, 2017–2024 (USD Million)
Table 43 Germany: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 44 UK: Key Macroindicators
Table 45 UK: Clinical Risk Grouping Solutions Market, By Product, 2017–2024 (USD Million)
Table 46 UK: Clinical Risk Grouping Solutions Market, By Deployment Model, 2017–2024 (USD Million)
Table 47 UK: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 48 France: Clinical Risk Grouping Solutions Market, By Product, 2017–2024 (USD Million)
Table 49 France: Clinical Risk Grouping Solutions Market, By Deployment Model, 2017–2024 (USD Million)
Table 50 France: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 51 RoE: Clinical Risk Grouping Solutions Market, By Product, 2017–2024 (USD Million)
Table 52 RoE: Clinical Risk Grouping Solutions Market, By Deployment Model, 2017–2024 (USD Million)
Table 53 RoE: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 54 Asia Pacific: Clinical Risk Grouping Solutions Market, By Product, 2017–2024 (USD Million)
Table 55 Asia Pacific: Clinical Risk Grouping Solutions Market, By Deployment Model, 2017–2024 (USD Million)
Table 56 Asia Pacific: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 57 Latin America: Clinical Risk Grouping Solutions Market, By Product, 2017–2024 (USD Million)
Table 58 Latin America: Clinical Risk Grouping Solutions Market, By Deployment Model, 2017–2024 (USD Million)
Table 59 Latin America: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 60 Middle East and Africa: Clinical Risk Grouping Solutions Market, By Product, 2017–2024 (USD Million)
Table 61 Middle East and Africa: Clinical Risk Grouping Solutions Market, By Deployment Model, 2017–2024 (USD Million)
Table 62 Middle East and Africa: Clinical Risk Grouping Solutions Market, By End User, 2017–2024 (USD Million)
Table 63 Product Launches and Enhancements (2017–2019)
Table 64 Acquisitions, Joint Ventures, and Mergers (2018–2019)
Table 65 Collaborations, Agreements, and Partnerships (2018–2019)
Table 66 Expansions (2017)

List of Figures (31 Figures)
Figure 1 Clinical Risk Grouping Solutions Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designations, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Clinical Risk Grouping Solutions Market, By Product, 2019 vs. 2024 (USD Million)
Figure 8 Clinical Risk Grouping Solutions Market, By Deployment Model, 2019 vs. 2024 (USD Million)
Figure 9 Clinical Risk Grouping Solutions Market, By End User, 2019 vs. 2024 (USD Million)
Figure 10 Geographical Snapshot of the Clinical Risk Grouping Solutions Market
Figure 11 Increasing Focus on Risk Management is the Major Factor Driving the Adoption of Clinical Risk Grouping Solutions
Figure 12 Asia Pacific Market to Register the Highest Growth During the Forecast Period
Figure 13 North America Will Continue to Dominate the Clinical Risk Grouping Solutions Market in 2024
Figure 14 Asia Pacific Market to Register Higher Growth Rates During the Forecast Period
Figure 15 Clinical Risk Grouping Solutions Market: Drivers, Restraints, Opportunities & Challenges
Figure 16 Healthcare Data Breaches in the Us (2016-2019)
Figure 17 Scorecard and Visualization Tools Segment to Dominate the Clinical Risk Grouping Solutions Market in 2019
Figure 18 Private Cloud to Hold the Largest Share of the Clinical Risk Grouping Solutions Market During the Forecast Period
Figure 19 Clinical Risk Grouping Solutions Market, By End User, 2019 vs. 2024
Figure 20 Clinical Risk Grouping Solutions Market: Geographic Snapshot
Figure 21 North America: Clinical Risk Grouping Solutions Market Snapshot
Figure 22 Europe: Clinical Risk Grouping Solutions Market Snapshot
Figure 23 Key Developments in the Clinical Risk Grouping Solutions Market Between 2016 and 2019
Figure 24 Clinical Risk Grouping Solutions Market: Competitive Leadership Mapping (2018)
Figure 25 3M and Optum are the Leading Players in the Clinical Risk Grouping Solutions Market
Figure 26 3M Company: Company Snapshot
Figure 27 Optum Inc.: Company Snapshot
Figure 28 Nuance Communications: Company Snapshot
Figure 29 Conduent Incorporated: Company Snapshot
Figure 30 Cerner: Company Snapshot
Figure 31 Evolent Health: Company Snapshot

★調査レポート[臨床的リスク分類ソリューションの世界市場予測（～2024年）] ( Clinical Risk Grouping Solutions Market by Product (Scorecard & Visualization Tools, Dashboard Analytics, Risk Reporting), Deployment (Private Cloud, Public Cloud, Hybrid Cloud), End-User and Region - Global Forecast to 2024 / HIT 7312) 販売に関する免責事項
[臨床的リスク分類ソリューションの世界市場予測（～2024年）] ( Clinical Risk Grouping Solutions Market by Product (Scorecard & Visualization Tools, Dashboard Analytics, Risk Reporting), Deployment (Private Cloud, Public Cloud, Hybrid Cloud), End-User and Region - Global Forecast to 2024 / HIT 7312) についてEメールでお問い合わせ
◆関連調査資料◆
  • 患者安全及びリスク管理ソフトウェアの世界市場予測（～2024年）
    HIT 7318 / MarketsandMarkets / 2019年8月30日 / 当調査レポートでは、患者安全及びリスク管理ソフトウェアの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別（リスク管理、ガバナンス、リスク及びコンプライアンス、クレーム管理）分析、展開モード別（クラウド、パブリック、プライベート）分析、エンドユーザー別（病院、外来診療、薬局）分析、患者安全及びリスク管理ソフトウェアの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。MarketsandMarkets社は、患者安全及びリスク管理ソフトウェアの世界市場規模が2019年13億万ドルから2024年22億万ドルまで年平均11.2%成長すると予測しています。...“The patient safety and risk management solutions market is projected to grow at a CAGR of 11.2%.”The global patient safety and risk management solutions market is projected to reach USD 2.2 billion by 2024 from USD 1.3 billion in 2019, at a CAGR of 11.2% during the forecast period. Increasing need to improve patient safety & patient outcomes in the healthcare industry in line with patient safety standards across the globe while enhancing the operational efficiency of healthcare organizations is expected to propel the growth of this market. On the other hand, reluctance to switch from conventional methods and lack...
  • がん患者登録ソフトウェアの世界市場予測（～2024年）
    HIT-6993 / MarketsandMarkets / 2019年3月28日 / がん患者登録ソフトウェアの世界市場は、2019年の5,500万米ドルから2024年には9,100万米ドルに達し、この期間中10.4％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、がんの罹患率の増加、政府による積極的な取り組み、EHRの採用の増加、市販直後調査を目的としたがん患者登録データの利用増加、医療の質の向上、医療費削減に対する意識の高まりなどが考えられます。一方で、プライバシーとデータセキュリティ関連の懸念により、市場の成長は抑制される可能性があります。当調査レポートでは、がん患者登録ソフトウェアの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、タイプ（スタンドアロン型、統合型）分析、導入モード（オンプレミス、クラウド）分析、データベース（民間、公共）分析、機能性（がん報告、患者ケア、医学研究）分析、がん患者登録ソフトウェアの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“Cancer patient registry software market projected to grow at a CAGR of 10.4%” The cancer patient registry software market is projected to reach USD 91 million by 2024 from USD 55 million in 2019, at a CAGR of 10.4%. Factors such as the growing prevalence of cancer, favorable government initiatives, rising adoption of EHRs, growing use of cancer patient registry data for post-marketing surveillance, and rising pressure to improve the quality of care and reduce healthcare costs are driving the growth of this market. However, privacy and data security-related concerns may restrain the growth of this market to a certain...
  • ヘルスケアにおける相互運用性ソリューションの世界市場予測（～2024年）
    HIT-6989 / MarketsandMarkets / 2019年3月28日 / ヘルスケアにおける相互運用性ソリューションの世界市場は、2019年の推定23億米ドルから2024年には42億米ドルに達し、この期間中12.6％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、患者中心の医療への関心の高まり、医療費の増加を抑制するニーズの高まり、患者の治療と安全性を向上させるための政府の取り組み、ヘルスケア相互運用性に対する政府の資金援助、さらにはヘルスケアインフラの改善が考えられます。一方で、一貫したデータがないことで複雑さが増すこと、訓練を受けた医療IT専門家が不足していること、そしてデータのプライバシーに関する懸念は、市場が抱える課題です。当調査レポートでは、ヘルスケアにおける相互運用性ソリューションの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、タイプ（EHR相互運用性、健康情報交換、企業）分析、相互運用性レベル（基礎的、構造的、意味的）分析、エンドユーザー分析、ヘルスケアにおける相互運用性ソリューションの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global healthcare interoperability solutions market is projected to grow at a CAGR of 12.6%.”The healthcare interoperability solutions market is projected to reach USD 4.2 billion by 2024 from an estimated USD 2.3 billion in 2019, at a CAGR of 12.6%. The growing focus on patient-centric care delivery, rising need to curb increasing healthcare costs, government initiatives for enhancing patient care and safety, and government funding for healthcare interoperability are the primary growth factors for this market. The growing improvements in healthcare infrastructure are expected to offer significant growth opportunities for players in this market. However, increasing complexity with lack...
  • ヘルスケア契約管理ソフトウェアの世界市場予測（～2024年）
    HIT 7147 / MarketsandMarkets / 2019年6月20日 / 当調査レポートでは、ヘルスケア契約管理ソフトウェアの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品＆サービス（契約ライフサイクル管理、文書管理）別分析、エンドユーザー（医療提供者、病院、医者、支払人、医療機器製造業者、製薬）別分析、ヘルスケア契約管理ソフトウェアの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The healthcare contract management software market is projected to grow at a CAGR of 18.5%.”The global healthcare contract management software market is projected to reach USD 1,763 million by 2024 from USD 755 million in 2019, at a CAGR of 18.5% during the forecast period. Rising demand for contract management software from healthcare providers, the growing need for healthcare insurance providers to efficiently manage an in-depth record of claims and reimbursements is expected to propel the growth of this market. On the other hand, reluctance to switch from conventional methods and the high costs involved for the implementation of this...
  • 医学用語ソフトウェアの世界市場予測（～2024年）
    HIT-6988 / MarketsandMarkets / 2019年3月28日 / 医療用語ソフトウェアの世界市場は、2019年の7億700万米ドルから2024年には17億8,600万米ドルに達し、この期間中20.4％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、医療過誤の最小化への注目の高まり、HCIT採用に向けた政府の取り組み、医療機関の専門用語の内容の不一致および細分化、データの整合性を維持する必要性の高まりなどが考えられます。一方で、慣習に倣うことよりも用語集ソフトウェアを使用することへの抵抗感は、市場の成長にとって大きな課題となっています。当調査レポートでは、医学用語ソフトウェアの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、用途（データ集約、償還、意思決定支援、臨床試験）分析、製品・サービス（サービス、プラットフォーム）分析、エンドユーザー（医療提供者、保険者、ITベンダー）分析、医学用語ソフトウェアの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The global medical terminology software market is projected to grow at a CAGR of 20.4% during 2019–2024.”The global medical terminology software market is projected to reach USD 1,786 million by 2024 from USD 707 million in 2019, at a CAGR of 20.4% from 2019 to 2024. The growth of this market is driven by factors such as the rising focus on minimizing medical errors, government initiatives for HCIT adoption, and disparity and fragmentation in the terminology content of healthcare organizations. The increasing need to maintain data integrity is expected to provide further growth opportunities for market players in the coming...
  • リスク分析の世界市場予測（～2024年）
    MAM90938 / MarketsandMarkets / 2019年8月16日 / 当調査レポートでは、リスク分析の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、ソフトウェア種類別（ETL、リスク計算エンジン、スコアカード、視覚化）分析、サービス別分析、リスク種類別（戦略的リスク、運用リスク、財務リスク）分析、展開モード別分析、リスク分析の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。MarketsandMarkets社は、リスク分析の世界市場規模が2019年230億ドルから2024年459億ドルまで年平均14.8%成長すると予測しています。...“Increasing level of complexity across business processes, and rising digitalization & business process automation is expected to drive the overall growth of risk analytics market”The risk analytics market size is expected to grow from USD 23.0 billion in 2019 to USD 45.9 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 14.8% during the forecast period. The risk analytics market is driven by various factors, such as increasing complexities across business processes, and rising digitalization & business process automation. However, the integration of data from data silos can hinder the growth of the market. “Services segment to grow...
  • 糖尿病のデジタル管理の世界市場予測（～2024年）
    MD 6871 / MarketsandMarkets / 2019年1月24日 / 糖尿病のデジタル管理の世界市場は、2019年の68億米ドルから2024年には199億米ドルに達し、この期間中23.8％の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、糖尿病の罹患率の上昇、糖尿病管理のためのクラウドベースのエンタープライズソリューションの採用の拡大、デジタルプラットフォームの普及の拡大、糖尿病管理向けモバイルアプリの採用、技術の進歩などが考えられます。一方で、発展途上国における高額な機器コストと医療費償還の欠如、そして従来からの糖尿病管理機器の普及により、市場の成長が妨げられる可能性があります。当調査レポートでは、糖尿病のデジタル管理の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、製品別（デバイス、糖尿病アプリ、サービス、データ管理ソフトウェア）分析、デバイスの種類別（ハンドヘルド、ウェアラブル）分析、エンドユーザー別（病院、在宅医療）分析、糖尿病のデジタル管理の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The Global Digital Diabetes Management Market is Projected to Grow at a CAGR of 23.8%.”The digital diabetes management market is projected to reach USD 19.9 billion by 2024 from USD 6.8 billion in 2019, at a CAGR of 23.8%. Factors such as the rising prevalence of diabetes, growing adoption of cloud-based enterprise solutions for diabetes management, increasing penetration of digital platforms and adoption of mobile apps for diabetes management, and technological advancements are driving the growth of the digital diabetes management market. However, high device costs and lack of reimbursement in developing countries and the higher acceptance of traditional diabetes...
  • 温度管理の世界市場予測（～2024年）
    MAM90939 / MarketsandMarkets / 2019年8月18日 / 当調査レポートでは、温度管理の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別（表面および血管内システム-加温および冷却）分析、用途別（周術期（術前ケア、手術室）、急性期ケア、新生児ケア）分析、医療専門別（小児科、整形外科）分析、温度管理の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。MarketsandMarkets社は、温度管理の世界市場規模が2019年26億ドルから2024年30億ドルまで年平均3.2%成長すると予測しています。...“Increase in the incidence of chronic conditions and the resultant increase in the number of surgical procedures to drive market growth”The temperature management market is projected to reach USD 3.0 billion by 2024 from 2.6 billion in 2019, at a CAGR of 3.2% during the forecast period. The growth of this market is driven by the increasing prevalence of chronic diseases and the subsequent increase in the number of surgical procedures. The growing number of contracts and agreements between market players is also expected to offer growth opportunities for market players during the forecast period. However, the high cost of...
  • 血液透析＆腹膜透析の世界市場予測（～2024年）：機械、透析装置、濃縮液、透析液、カテーテル
    MD 2157 / MarketsandMarkets / 2019年7月2日 / 当調査レポートでは、血液透析＆腹膜透析の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、製品別（機械、透析装置、濃縮液、透析液、カテーテル）分析、サービス別分析、モダリティ別（従来型、CAPD、夜間）分析、エンドユーザー別（病院、独立透析センター、在宅透析）分析、血液透析＆腹膜透析の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...“The hemodialysis and peritoneal dialysis market is projected to grow at a CAGR of 6.0% during the forecast period.”The hemodialysis and peritoneal dialysis market is projected to reach USD 99.2 billion by 2024 from USD 74.2 billion in 2019, at a CAGR of 6.0%. Growth in this market is largely driven by factors such as the increasing number of ESRD patients, growing prevalence of diabetes & hypertension, preference for dialysis treatments over kidney transplants, and initiatives taken by leading players to introduce advanced products & services. However, the risks & complications associated with dialysis, low consumer awareness regarding kidney diseases,...
  • 電子治験マスターファイル (eTMF) システムの世界市場予測（～2024年）
    HIT 7315 / MarketsandMarkets / 2019年8月30日 / 当調査レポートでは、電子治験マスターファイル (eTMF) システムの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、コンポーネント別（サービス、ソフトウェア）分析、エンドユーザー別（製薬およびバイオテクノロジー企業、受託研究機関）分析、配信モード別（オンプレミス、クラウドベース）分析、電子治験マスターファイル (eTMF) システムの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。MarketsandMarkets社は、電子治験マスターファイル (eTMF) システムの世界市場規模が2019年10億万ドルから2024年18億万ドルまで年平均12.7%成長すると予測しています。...“The eTMF systems market is projected to grow at a CAGR of 12.7% during the forecast period.”The electronic trial master file (eTMF) systems market is projected to reach USD 1.8 billion by 2024 from USD 1.0 billion in 2019, at a CAGR of 12.7%. Growth in the eTMF systems market can be attributed primarily to the rising adoption of eTMF systems, a growing number of clinical trials, partnerships between biopharma companies & CROs, increasing funding to support clinical trials, and the growth in the R&D spending by pharma & biotech companies. Emerging countries are expected to provide significant opportunities for...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆